ClinicalTrials.gg
RecruitingNCT07651072AIDE/OBS/2025Updated Nov 6, 2026

AIDE: Decision Support for Anastomosis or Colostomy in Emergency Surgery for Complicated Acute Diverticulitis

An observational study in Complicated Diverticulitis, Acute Diverticulitis and Peritonitis, sponsored by IRCCS San Raffaele Roma. Recruiting at 2 sites in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by IRCCS San Raffaele Roma · Observational

From the registry’s dates

  • Started May 2026; still recruiting 5 months later.
Updated Nov 6, 2026Now RecruitingStart date moved+4 moreGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
150
Ages
18 Years and older
Sex
All
01

Study summary

The AIDE/OBS study is a multicenter, observational, non-interventional study designed to collect standardized clinical, radiological, intraoperative visual, and surgical reasoning data from adult patients undergoing non-elective surgery for complicated acute diverticulitis.

The study focuses on patients requiring urgent or emergency operative management, including cases following failure of non-operative management. The main intraoperative decision of interest is the choice between sigmoid resection with primary anastomosis, with or without diverting stoma, and Hartmann's procedure.

The current phase aims to build a structured multimodal dataset and to validate and refine a preliminary expert-informed decision-support tool. The study does not modify standard clinical practice, surgical indication, operative strategy, or postoperative management. All treatment decisions remain at the discretion of the treating surgical team according to local practice.

Read the detailed description

Complicated acute diverticulitis requiring non-elective surgery remains a challenging condition in emergency colorectal surgery. In patients with diffuse peritonitis or severe complicated disease, the intraoperative decision between primary anastomosis and Hartmann's procedure is complex and influenced by patient-related factors, disease severity, contamination, tissue quality, bowel perfusion, technical feasibility, and surgeon judgment.

The AIDE/OBS study aims to collect retrospectively and prospectively standardized real-world data from multiple centers to better understand the factors influencing this decision. The study will collect clinical and demographic characteristics, comorbidities, radiological findings including WSES CT-driven classification, intraoperative findings, operative strategy, postoperative outcomes, anonymized intraoperative images or videos when available, and surgeon-reported decision-making factors.

The collected data will be used to validate and refine a preliminary expert-informed AI-based decision-support framework. The long-term objective is to support the development of future artificial intelligence and computer vision tools that may assist emergency surgeons during intraoperative decision-making in complicated diverticulitis.

This is an observational, non-interventional study. No experimental treatment, device, or AI-guided recommendation is applied to patients during the study. Surgical management is performed according to standard clinical practice and local protocols.

02

Conditions studied

  • Complicated Diverticulitis
  • Acute Diverticulitis
  • Peritonitis
  • Perforated Diverticulitis

Browse trials for

Keywords

  • Perforated diverticulitis
  • Emergency surgery
  • Non-elective surgery
  • Primary anastomosis
  • Hartmann's procedure
  • Intraoperative decision-making
  • Artificial intelligence
  • Computer vision
  • Surgical video analysis
  • Multimodal dataset
03

In context

Peritonitis

167 studies on the registry are indexed under Peritonitis; 23 are open to participants now.

This study's planned enrollment of 150 is close to the median of 137 across 55 observational studies indexed under Peritonitis.

Browse Peritonitis studies →

Lead sponsor

IRCCS San Raffaele Roma is the lead sponsor of 71 studies on the registry; 25 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult patients undergoing non-elective surgery for acute complicated diverticulitis at participating centers. Eligible patients include those requiring emergency or urgent operative management, including cases after failure of non-operative treatment, according to local clinical practice.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older
  • Diagnosis of acute complicated diverticulitis requiring non-elective operative management
  • Emergency or urgent surgery for complicated diverticulitis, including surgery after failure of non-operative management
  • Minimally invasive approach: laparoscopic/robotic surgery
  • Patients undergoing sigmoid resection with primary anastomosis, Hartmann's procedure, or other operative strategy according to local practice
  • Availability of clinical and operative data
  • Local ethical approval, authorization, or waiver according to national and institutional regulations

Exclusion criteria

Exclusion Criteria:

  • Age younger than 18 years
  • Elective surgery for diverticular disease
  • Uncomplicated diverticulitis managed non-operatively
  • Surgery performed for conditions not related to diverticulitis
  • Surgical procedures performed via primary open approach (i.e., no attempt at minimally invasive surgery), unless converted intraoperatively.
  • Lack of required consent or authorization for data use, when required by local regulations
05

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
150 participants (estimated)
Patient registry
No

Groups and cohorts

  • Primary Anastomosis Group

    Patients undergoing sigmoid resection with primary anastomosis, with or without diverting stoma, for complicated acute diverticulitis in a non-elective surgical setting.

    Procedure: Primary anastomosis

  • Hartmann's Procedure Group

    Patients undergoing sigmoid resection with end colostomy and rectal stump closure for complicated acute diverticulitis in a non-elective surgical setting.

    Procedure: Hartmann's procedure

Interventions

  • ProcedurePrimary anastomosis

    Observed surgical strategy consisting of sigmoid resection with colorectal anastomosis, with or without diverting stoma, performed according to standard clinical practice. The study does not assign this procedure.

  • ProcedureHartmann's procedure

    Observed surgical strategy consisting of sigmoid resection with end colostomy and rectal stump closure, performed according to standard clinical practice. The study does not assign this procedure.

06

What researchers measure

Primary outcomes

  1. Clinical, radiological, intraoperative visual, and surgeon-reported factors associated with the intraoperative decision to perform primary anastomosis versus Hartmann's procedure

    Structured analysis of patient-related, disease-related, imaging-related, intraoperative, and surgeon-reported factors influencing the choice between primary anastomosis and Hartmann's procedure in non-elective surgery for complicated diverticulitis.

    Time frame: Assessed intraoperatively during the index emergency surgical procedure and recorded at completion of operative case data entry.

Secondary outcomes

  1. Rate of primary anastomosis versus Hartmann's procedure

    Proportion of patients undergoing primary anastomosis, with or without diverting stoma, compared with Hartmann's procedure.

    Time frame: Assessed intraoperatively during the index emergency surgical procedure.

  2. Completeness of standardized intraoperative visual data acquisition

    Proportion of cases with uploaded anonymized intraoperative images or videos according to the predefined study phases.

    Time frame: From the start of the index emergency surgical procedure until completion of intraoperative image or video acquisition, assessed up to the end of the operation.

  3. Anastomotic leak rate

    Rate of clinically or radiologically diagnosed anastomotic leak among patients receiving primary anastomosis.

    Time frame: From the date of surgery until 30 postoperative days.

  4. Postoperative morbidity

    Rate of postoperative complications after non-elective surgery for complicated diverticulitis.

    Time frame: Assessed during index hospitalization and up to 30 postoperative days.

  5. Stoma creation rate

    Proportion of patients receiving a stoma during the index operation.

    Time frame: Assessed intraoperatively during the index emergency surgical procedure.

  6. Length of hospital stay

    Duration of hospital stay after the index operation.

    Time frame: From the date of the index emergency surgical procedure until hospital discharge, assessed up to 90 days.

  7. Mortality

    All-cause postoperative mortality

    Time frame: From the date of surgery up to 30 postoperative days.

  8. Proportion of enrolled cases with complete standardized clinical and intraoperative visual datasets

    Feasibility will be assessed as the proportion of enrolled patients for whom the participating center successfully submits a complete standardized dataset, including required clinical variables, radiological classification, intraoperative decision-making form, and standardized intraoperative visual material according to the study protocol. A complete visual dataset will be defined as submission of the required intraoperative images or video frames for the predefined operative phases, when technically feasible.

    Time frame: From study initiation until completion of participant enrollment and database closure, estimated up to 24 months.

07

Study locations

2 of 2 sites recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Undecided

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2026 (actual). Primary completion is estimated for Dec 2029, 43 months after the start.

Of 23 observational studies under Peritonitis, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 34. This study's planned 43 months is above that.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 6, 2026: primary completion Apr 2028 → Dec 2029 and completion Apr 2028 → Dec 2029.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
May 25, 2026
First posted
Jun 16, 2026
StartActual
May 15, 2026
Primary completionEst.
Dec 31, 2029was Apr 2028
CompletionEst.
Dec 31, 2029was Apr 2028
Last update
Nov 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 6, 2026
Sites
2 sites added, 1 site removed
Show 2 added (2 Italy)
  • eCampus university · Novedrate, Italy
  • IRCCS San Raffaele Roma · Roma, Italy
Show 1 removed
  • ASL Romagna · Cesena, Italy
Nov 6, 2026
Start date
May 31, 2026→May 15, 2026 (actual)
Nov 6, 2026
Primary completion
Apr 30, 2028→Dec 31, 2029
Nov 6, 2026
Study completion
Apr 30, 2028→Dec 31, 2029
Nov 6, 2026
Show all 1 update
  1. Nov 6, 2026
    Not yet recruiting→Recruiting
    2 sites added, 1 site removed
    Show 2 added (2 Italy)
    • eCampus university · Novedrate, Italy
    • IRCCS San Raffaele Roma · Roma, Italy
    Show 1 removed
    • ASL Romagna · Cesena, Italy
    Start date May 31, 2026→May 15, 2026 (now actual)
    Primary completion Apr 30, 2028→Dec 31, 2029
    Study completion Apr 30, 2028→Dec 31, 2029
    + 2 other changes: verification date and responsible party

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07651072
Lead sponsor
IRCCS San Raffaele Roma
Collaborators
World Society of Emergency Surgery
Responsible party
Sponsor
First posted
Jun 16, 2026
Start date
May 15, 2026
Primary completion
Dec 31, 2029 (estimated)
Completion
Dec 31, 2029 (estimated)
Last update
Nov 6, 2026

Study contacts

Belinda De Simone, MD
Contact
ariesproject2023@gmail.com
+33665787872

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion